Exosomes/Extracellular Vesicles

 

Category: Cell Therapy and Regenerative Medicine

Exhibitor: TRANSWELL BIOTECH CO., LTD.

Booth No: N602

 

Characteristic

 

TRANSWELL BIOTECH CO., LTD. is dedicated to developing technologies for the isolation, purification, and lyophilization of extracellular vesicles (EVs) and exosomes. The sources of these EVs and exosomes include chicken embryonic cells, human dermal fibroblasts, human umbilical cord mesenchymal stem cells (UC-MSC), and human umbilical vein endothelial cells (HUVEC). Analysis and quantification are conducted using nanoparticle tracking analysis (NTA).

Cell and animal experiments have demonstrated that the EVs and exosomes produced by our company can promote the proliferation of dermal fibroblasts and dermal papilla cells, enhance collagen secretion by dermal fibroblasts, reduce damage caused by free radicals and oxidative stress, inhibit immune cells, improve lung fibrosis, and enhance lung function in mice. The EVs and exosomes developed by TRANSWELL BIOTECH CO., LTD. are intended for use in new drug development and as ingredients in cosmetic and skincare products.

 

Other Products

 

• 

  TWB-103 Allogeneic Dermal Fibroblast Cell Therapy Product

• 

  EpiV Serum-free, Chemically-defined Epithelial Cell Culture Medium

• 

  auniGEL Hydrogel

• 

  Hydrogel Skincare product

• 

  Cell-fm

 

 

 

Back